Global Facial Injectables Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Facial Injectables Market is presumed to reach the market size of nearly USD 32.01 BN by 2030 from USD 11.59 BN in 2022 with a CAGR of 13.54% under the study period 2023 - 2030.

Facial injectables refer to non-surgical cosmetic treatments involving the injection of substances into various facial areas to enhance appearance, reduce wrinkles, restore volume, and rejuvenate skin texture. These injectable treatments are administered by qualified medical professionals, typically dermatologists or plastic surgeons, to address various aesthetic concerns and achieve desired facial enhancements.

MARKET DYNAMICS

The facial injectables market exhibits growth owing to various influential factors shaping consumer preferences and the cosmetic industry. An aging population's desire for youthful looks drives demand for facial injectables, offering solutions for wrinkles, fine lines, and facial volume loss. Non-surgical options' popularity, due to their minimal invasiveness and reduced downtime, fuels the market's expansion as accessible alternatives to traditional surgery. Continual advancements in injectable technologies, improved formulations, and innovative delivery methods enhance product efficacy, safety, and durability, fostering wider acceptance. Social media and celebrity influences significantly impact consumer perceptions, encouraging more individuals to consider facial injectables for aesthetic enhancements. Increased awareness, reduced stigma, and personalized treatment plans cater to diverse aesthetic needs, making facial injectables more accessible. Economic factors, affordability options, and rising male interest in cosmetic procedures further contribute to the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of facial injectables. The growth and trends of facial injectables industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the facial injectables market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Collagen & PMMA Microspheres
Hyaluronic Acid (HA)
Botulinum Toxin Type A
Calcium Hydroxylapatite (CaHA)
Poly-L-Lactic Acid (PLLA)
Others

By Application

Facial Line Correction
Lip Augmentation
Face Lift
Acne Scar Treatment
Lipoatrophy Treatment
Others

By End-Use

MedSpas
Dermatology Clinics
Hospitals

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Facial Injectables market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Facial Injectables market include Ispen, Abbvie, Medytox Inc., Merz GmbH and Co., KGaA, Revance Therapeutics Inc., Galderma, Sinclair Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112985

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . FACIAL INJECTABLES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Collagen & PMMA Microspheres Historic and Forecast Sales by Regions
5.5 Hyaluronic Acid (HA) Historic and Forecast Sales by Regions
5.6 Botulinum Toxin Type A Historic and Forecast Sales by Regions
5.7 Calcium Hydroxylapatite (CaHA) Historic and Forecast Sales by Regions
5.8 Poly-L-lactic Acid (PLLA) Historic and Forecast Sales by Regions
5.9 Others Historic and Forecast Sales by Regions

6 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY APPLICATION

6.1 Overview by Application
6.2 Historical and Forecast Data
6.3 Analysis by Application
6.4 Facial Line Correction Historic and Forecast Sales by Regions
6.5 Lip Augmentation Historic and Forecast Sales by Regions
6.6 Face Lift Historic and Forecast Sales by Regions
6.7 Acne Scar Treatment Historic and Forecast Sales by Regions
6.8 Lipoatrophy Treatment Historic and Forecast Sales by Regions
6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY END-USE

7.1 Overview by End-use
7.2 Historical and Forecast Data
7.3 Analysis by End-use
7.4 MedSpas Historic and Forecast Sales by Regions
7.5 Dermatology Clinics Historic and Forecast Sales by Regions
7.6 Hospitals Historic and Forecast Sales by Regions

8 . GLOBAL FACIAL INJECTABLES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE FACIAL INJECTABLES COMPANIES

9.1. Facial Injectables Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF FACIAL INJECTABLES INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Ispen
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Abbvie
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Medytox Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Merz GmbH and Co. KGaA
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Revance Therapeutics Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Galderma
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Sinclair Pharma
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies